{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T11:04:06Z","timestamp":1787828646991,"version":"build-2784847793"},"reference-count":14,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.ejca.2017.01.028","type":"journal-article","created":{"date-parts":[[2017,3,17]],"date-time":"2017-03-17T05:09:13Z","timestamp":1489727353000},"page":"118-124","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":149,"special_numbering":"C","title":["Denosumab in advanced\/unresectable giant-cell tumour of bone (GCTB): For how long?"],"prefix":"10.1016","volume":"76","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3406-6705","authenticated-orcid":false,"given":"E.","family":"Palmerini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.S.","family":"Chawla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Sudan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Picci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Marchesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Piccinni","family":"Leopardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Syed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.K.","family":"Sankhala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Parthasarathy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.E.","family":"Mendanha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Pierini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Paioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.P.","family":"Chawla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2017.01.028_bib1","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1097\/01.coc.0000195089.11620.b7","article-title":"Giant cell tumor of bone","volume":"29","author":"Mendenhall","year":"2006","journal-title":"Am J Clin Oncol"},{"issue":"1","key":"10.1016\/j.ejca.2017.01.028_bib2","doi-asserted-by":"publisher","first-page":"E37","DOI":"10.1097\/BRS.0b013e3182233ccd","article-title":"Giant cell tumor of the mobile spine: a review of 49 cases","volume":"37","author":"Boriani","year":"2012","journal-title":"Spine (Phila Pa 1976)"},{"key":"10.1016\/j.ejca.2017.01.028_bib3","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1097\/00003086-199602000-00008","article-title":"Giant cell tumor of bone","volume":"323","author":"Yip","year":"1996","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.ejca.2017.01.028_bib4","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1097\/00003086-199902000-00019","article-title":"Cryosurgery in the treatment of giant cell tumor. A long-term followup study","volume":"359","author":"Malawer","year":"1999","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.ejca.2017.01.028_bib5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ctrv.2009.09.002","article-title":"Giant cell tumor of the extremity: a review of 349 cases from a single institution","volume":"36","author":"Errani","year":"2010","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.ejca.2017.01.028_bib6","unstructured":"http:\/\/www.fda.gov\/Drugs\/InformationOnDrugs\/ApprovedDrugs\/ucm356667.htm."},{"key":"10.1016\/j.ejca.2017.01.028_bib7","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/S1470-2045(13)70277-8","article-title":"Safety and efficacy of denosumab for adults and skeletally mature adolescents with giant cell tumour of bone: interim analysis of an open-label parallel-group, phase 2 study","volume":"14","author":"Chawla","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2017.01.028_bib8","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1359\/JBMR.040305","article-title":"A single-dose placebo-controlled study of AMG 162, a fully human monoclonal antibody to RANKL, in postmenopausal women","volume":"19","author":"Bekker","year":"2004","journal-title":"J Bone Miner Res"},{"issue":"1","key":"10.1016\/j.ejca.2017.01.028_bib9","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s00520-015-2904-5","article-title":"Safety of long-term denosumab therapy: results from the open label extension phase of two phase 3 studies in patients with metastatic breast and prostate cancer","volume":"24","author":"Stopeck","year":"2016","journal-title":"Support Care Cancer"},{"issue":"9","key":"10.1016\/j.ejca.2017.01.028_bib10","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.3109\/0284186X.2014.910313","article-title":"Effects of denosumab on pain and analgesic use in giant cell tumor of bone: interim results from a phase II study","volume":"53","author":"Martin-Broto","year":"2014","journal-title":"Acta Oncol"},{"issue":"3","key":"10.1016\/j.ejca.2017.01.028_bib11","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/S1470-2045(10)70010-3","article-title":"Denosumab in patients with giant-cell tumour of bone: an open-label, phase 2 study","volume":"11","author":"Thomas","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2017.01.028_bib12","doi-asserted-by":"crossref","first-page":"4312","DOI":"10.3892\/ol.2016.5246","article-title":"Denosumab treatment of inoperable or locally advanced giant cell tumor of bone","volume":"12","author":"Borkowska","year":"2016","journal-title":"Oncol Lett"},{"key":"10.1016\/j.ejca.2017.01.028_bib13","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1200\/JCO.2006.07.3049","article-title":"Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: proposal of new computed tomography response criteria","volume":"25","author":"Choi","year":"2007","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.ejca.2017.01.028_bib14","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13569-016-0056-0","article-title":"Current status and unanswered questions on the use of denosumab in giant cell tumor of bone","volume":"6","author":"Gaston","year":"2016","journal-title":"Clin Sarcoma Res"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804917307104?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804917307104?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,19]],"date-time":"2019-09-19T17:47:48Z","timestamp":1568915268000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804917307104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":14,"alternative-id":["S0959804917307104"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2017.01.028","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Denosumab in advanced\/unresectable giant-cell tumour of bone (GCTB): For how long?","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2017.01.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}